References
- Esteban J I, González A, Hernández J M, et al. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 1990; 323: 1107–12
- Feinman S V, Berris B, Bojarski S. Posttransfusion hepatitis in Toronto, Canada. Gastroenterology 1988; 95: 464–9
- Colombo M, Oldani S, Donato M F, et al. A multicenter, prospective study of posttransfusion hepatitis in Milan. Hepatology 1987; 7: 709–12
- Grillner L, Bergdahl S, Jyrälä A. Non-A, non-B hepatitis after open-heart surgery in Sweden. Scand J Infect Dis 1982; 14: 171–5
- Mattsson L, Åberg B, Weiland O, Sellman M, Davilén J. Non-A, non-B hepatitis after open-heart surgery in Stockholm: declining incidence after the introduction of restrictions for blood donations due to the human immunodeficiency virus. Scand J Infect Dis 1988; 20: 371–6
- Aach R D, Szmuness W, Mosley J W, et al. Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients. N Engl J Med 1981; 304: 889–994
- Alter H J, Purcell R H, Holland P V, Ailing D W, Koziol D E. Donor transaminase and recipient hepatitis. Impact on blood transfusion services. JAMA 1981; 246: 630–4
- Stevens C E, Aach R D, Hollinger F B, et al. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. Ann Intern Med 1984; 101: 733–8
- Koziol D, Holland P V, Ailing D W, et al. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 1986; 104: 488–95
- Hoyos M, Sarrión J V, Pérez-Castellanos T, et al. Prospective assessment of donor blood screening for antibody to hepatitis B core antigen as a means of preventing posttransfusion non-A, non-B hepatitis. Hepatology 1989; 9: 449–51
- van der Poel C L, Reesink H W, Schaasberg W, et al. Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet 1990; 335: 558–60
- Choo Q L, Kuo G, Weiner A J, Overby L R, Bradley D W, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359–62
- Kuo G, Choo O L, Alter H J, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362–4
- Contreras M, Barbara J AJ, Anderson C C, et al. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology. Lancet 1991; 337: 753–7
- van der Poel C L, Cuypers H TM, Reesink H W, et al. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 1991; 337: 317–9
- Shev S, Foberg U, Frydén A, et al. Anti-HCV ELISA positiva blodgivare: resultat av utvidgad hepatit C diagnostik och lever-biopsi [abstract]. Hygiea 1991; 100: 167
- Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidiniurn thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156–9
- Cristiano K, Di Bisceglie A M, Hoofnagle J H, Feinstone S M. Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets. Hepatology, In press
- Widell A, Persson A S, Sundström G, Hansson B G, Nordenfelt E. Hepatitis C virus RNA in blood donor sera detected by polymerase chain reaction. Comparison with confirmatory hepatitis C antibody assays. J Med Virol., In press
- Okamoto H, Okada S, Sugiyama Y, et al. The 5′-terminal sequence of the hepatitis C virus genome. Jpn J Exp Med 1990; 60: 167–76
- Ebeling F. Alanine aminotransferase, gamma-glutamyltransferase, antibodies to hepatitis B core antigen and antibodies to hepatitis C virus in blood donor screening. Vox Sang 1991; 60: 219–24
- Sirchia G, Bellobuono A, Giovanetti A, Marconi M. Antibodies to hepatitis C virus in Italian blood donors. Lancet 1989; 1: 797
- Kühnl P, Seidl S, Stangel W, Beyer J, Sibrowski W, Flik J. Antibody to hepatitis C virus in German blood donors. Lancet 1989; 2: 324
- Janot C, Couroucé A M, Manicz M. Antibodies to hepatitis C virus in French blood donors. Lancet 1989; 1: 796–7
- Ohkoshi S, Kojima H, Tawaraya H, et al. Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellular carcinoma. Jpn J Cancer Res 1990; 81: 550–3
- Saito I, Miyamura T, Ohbayashi A, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 6547–9
- Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671–5